Microarray Analysis of Gene Expression in Prostate Tissues
NCT00186368 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 867
Last updated 2026-01-12
Summary
The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.
Conditions
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
University of Wisconsin, Madison
collaborator OTHER -
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
James Brooks, MD · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-04-06
- Primary Completion
- 2009-04-21
- Completion
- 2009-04-21
Countries
- United States
Study Locations
More Related Trials
-
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
NCT03237026 ·Status: RECRUITING
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
NCT04396808 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Micro-RNA Expression Profiles in High Risk Prostate Cancer
NCT01220427 ·Status: TERMINATED
-
Identification of Prostate Cancer Genes
NCT00342784 ·Status: COMPLETED
-
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer
NCT00899912 ·Status: COMPLETED
-
MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients
NCT00165386 ·Status: COMPLETED ·Phase: NA
-
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 ·Status: UNKNOWN
-
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 ·Status: SUSPENDED
-
Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer
NCT01615965 ·Status: UNKNOWN ·Phase: NA
-
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
NCT01826617 ·Status: COMPLETED
-
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
NCT01350180 ·Status: WITHDRAWN
-
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02594202 ·Status: RECRUITING
-
The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy
NCT02573636 ·Status: RECRUITING
-
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
NCT01024959 ·Status: COMPLETED ·Phase: NA
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures
NCT02936258 ·Status: UNKNOWN ·Phase: NA
-
Protein Kinase A in Prostate Cancer Tissue.
NCT05460312 ·Status: UNKNOWN
-
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
NCT03488706 ·Status: UNKNOWN
-
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
NCT04981223 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches
NCT03632655 ·Status: TERMINATED ·Phase: NA
-
Metabolomic Study for Localized Prostate Cancer
NCT01968538 ·Status: UNKNOWN
-
Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate
NCT02882958 ·Status: COMPLETED